QVT Financial Purchase $20M of Convertible Debt Issued by VIVU...

HONG KONG, Dec. 27, 2012 /PRNewswire/ -- QVT Financial LP (together with its funds under management, "QVT") opposes and intends to vote against the reappointment of China Assets Investment Management Limited ("CAIML") as the investment manager of ...

T. Boone Pickens has lost a lot of money by investing big in the wind and solar sectors. After betting and losing big in renewable energy, he admitted in 2012 that he doesn't think the time to transition to wind and solar is now. Philip Falcone is ...

Vivus Inc. (VVUS) J. Martin Carroll and Jorge Plutzky joined the board, the Mountain View, California-based drugmaker said in a statement today. On April 30, the company said it appointed Robert N. Wilson. The additions bring the size of Vivus's ...

The Financial Times reports some of the biggest hedge funds are moving heaps of cash into Greece's banking sector in hopes of major returns. Farallon Capital, York Capital Management, QVT Financial and Dromeus are among hedge funds that are set to ...

Some of the world's leading hedge funds are pouring money into the Greek banking sector in expectation of huge potential returns, even as the country struggles to right its economy in the face of deep government spending cuts. Farallon Capital, York ...

Editor's Note: Related Tickers: II-VI, Inc. (NASDAQ:IIVI), Westpac Banking Corporation (ASX:WBC), UBS AG (USA) (NYSE:UBS), Deutsche Bank AG (USA) (NYSE:DB), Citigroup Inc. (NYSE:C), Sequenom, Inc. (NASDAQ:SQNM) Hedge Fund Manager Believes Gold ...

Acceleron Pharma, Inc., a biopharmaceutical company developing protein therapeutics for cancer and orphan hematologic diseases, today announced that preclinical research conducted by Acceleron scientists on the ACE-536 program received the Tito ...

Infinity Pharmaceuticals Inc. (NASDAQ: INFI ) was in 22 hedge funds portfolio at the end of December. INFI has experienced an increase in enthusiasm from smart money of late. There were 16 hedge funds in our database with INFI holdings at the end of ...

Vivus Inc. (VVUS), maker of the obesity drug Qsymia, said it's in talks with large pharmaceutical companies to explore ways to increase use of the medicine amid investor unrest over disappointing sales. The shares rose. Approved in July, Qsymia was ...